Advertisement
Screener

Merck & Co., Inc. (MRK) ROA

Merck & Co., Inc. ROA

Return on assets (ROA) is the profit a company earns for every dollar of assets it uses, shown as a percentage. It is net income divided by total assets, and the table shows both amounts. Because assets are funded by lenders as well as shareholders, ROA is not inflated by borrowing the way ROE can be, and it is naturally lower for businesses that need many factories, stores or other assets. Quarterly points divide the trailing four quarters of net income by the balance at that quarter end; annual points divide the filed fiscal-year net income by the fiscal-year-end balance.

  • Merck & Co., Inc. roa for the quarter ending 2026-06-30 was 2.44%, a 82.49% decline year-over-year.
  • Merck & Co., Inc. roa for the quarter ending 2026-03-31 was 6.94%, a 54.15% decline year-over-year.
  • Merck & Co., Inc. roa for the quarter ending 2025-12-31 was 13.34%, a 8.75% decline year-over-year.
  • Merck & Co., Inc. roa for the quarter ending 2025-09-30 was 14.69%, a 42.15% increase year-over-year.
  • Merck & Co., Inc. roa for fiscal 2025 was 13.34%, a 8.75% decline from fiscal 2024.
  • Merck & Co., Inc. roa for fiscal 2024 was 14.62%, a 4171.87% increase from fiscal 2023.
  • Merck & Co., Inc. roa for fiscal 2023 was 0.34%, a 97.43% decline from fiscal 2022.
  • Merck & Co., Inc. roa for fiscal 2022 was 13.30%, a 7.73% increase from fiscal 2021.
Available history
2008-12-31 to 2026-06-30
Data captured

Historical ROA

DateROANet income 12 monthNet income 3 monthTotal assets
2026-06-302.44%$3.17B-$1.33B$129.8B
2026-03-316.94%$8.94B-$4.24B$128.69B
2025-12-3113.34%$18.25B$2.96B$136.87B
2025-09-3014.69%$19.03B$5.79B$129.55B
2025-06-3013.96%$16.41B$4.43B$117.52B
2025-03-3115.14%$17.43B$5.08B$115.12B
2024-12-3114.62%$17.12B$3.74B$117.11B
2024-09-3010.34%$12.15B$3.16B$117.53B
2024-06-3012.20%$13.74B$5.46B$112.63B
2024-03-312.18%$2.31B$4.76B$105.85B
2023-12-310.34%$365M-$1.23B$106.68B
2023-09-304.32%$4.61B$4.75B$106.73B
2023-06-302.98%$3.11B-$5.97B$104.47B
2023-03-3112.09%$13.03B$2.82B$107.8B
2022-12-3113.30%$14.52B$3.02B$109.16B
2022-09-3014.25%$15.26B$3.25B$107.08B
2022-06-3015.48%$16.58B$3.94B$107.1B
2022-03-3113.29%$14.18B$4.31B$106.67B
2021-12-3112.35%$13.05B$3.05B$105.69B
2021-09-307.70%$7.2B$4.57B$93.49B
2021-06-306.14%$5.57B$1.54B$90.69B
2021-03-317.74%$7.03B$3.18B$90.85B
2020-12-317.72%$7.07B-$2.09B$91.59B
2020-09-3012.83%$11.52B$2.94B$89.8B
2020-06-3011.56%$10.48B$3.00B$90.62B
2020-03-3111.95%$10.15B$3.22B$84.91B
2019-12-3111.66%$9.84B$2.36B$84.4B
2019-09-3011.18%$9.31B$1.90B$83.33B
2019-06-3011.15%$9.36B$2.67B$83.97B
2019-03-3110.20%$8.4B$2.92B$82.35B
2018-12-317.53%$6.22B$1.83B$82.64B
2018-09-303.93%$3.35B$1.95B$85.13B
2018-06-301.58%$1.34B$1.71B$85.04B
2018-03-311.84%$1.58B$736.00M$86.04B
2017-12-312.73%$2.4B-$1.05B$87.87B
2017-09-303.10%$2.85B-$56.00M$91.68B
2017-06-305.48%$5.09B$1.95B$92.8B
2017-03-314.50%$4.35B$1.55B$96.56B
2016-12-314.11%$3.92B-$595.00M$95.38B
2016-09-305.58%$5.49B$2.18B$98.34B
2016-06-305.32%$5.13B$1.21B$96.48B
2016-03-314.67%$4.62B$1.13B$98.76B
2015-12-314.37%$4.44B$977.00M$101.68B
2015-09-3010.65%$10.78B$1.83B$101.23B
2015-06-309.60%$9.85B$687.00M$102.58B
2015-03-3110.31%$11.17B$953.00M$108.35B
2014-12-3112.14%$11.92B$7.32B$98.17B
2014-09-305.29%$5.39B$895.00M$101.81B
2014-06-305.74%$5.61B$2.00B$97.86B
2014-03-314.16%$4.52B$1.71B$108.46B
2013-12-314.17%$4.4B$781.00M$105.65B
2013-09-304.26%$4.53B$1.12B$106.42B
2013-06-304.80%$5.14B$906.00M$106.88B
2013-03-315.67%$6.02B$1.59B$106.2B
2012-12-315.81%$6.17B$907.00M$106.13B
2012-09-306.37%$6.77B$1.73B$106.3B
2012-06-306.38%$6.74B$1.79B$105.53B
2012-03-316.60%$6.97B$1.74B$105.51B
2011-12-315.97%$6.27B$1.51B$105.13B
2011-09-303.97%$4.23B$1.69B$106.53B
2011-06-302.71%$2.88B$2.02B$106.2B
2011-03-311.52%$1.61B$1.04B$105.87B
2010-12-310.81%$861M-$532.00M$105.78B
2010-09-307.31%$7.89B$342.00M$107.84B
2010-06-3010.33%$10.97B$752.00M$106.17B
2010-03-3110.55%$11.77B$299.00M$111.59B
2009-12-3111.48%$12.9B$6.49B$112.31B
2009-09-3041.98%$12.82B$3.42B$30.55B
2009-06-3033.90%$10.01B$1.56B$29.55B

Annual ROA

DateROANet income 12 monthTotal assets
2025-12-3113.34%$18.25B$136.87B
2024-12-3114.62%$17.12B$117.11B
2023-12-310.34%$365M$106.68B
2022-12-3113.30%$14.52B$109.16B
2021-12-3112.35%$13.05B$105.69B
2020-12-317.72%$7.07B$91.59B
2019-12-3111.66%$9.84B$84.4B
2018-12-317.53%$6.22B$82.64B
2017-12-312.72%$2.39B$87.87B
2016-12-314.11%$3.92B$95.38B
2015-12-314.37%$4.44B$101.68B
2014-12-3112.14%$11.92B$98.17B
2013-12-314.17%$4.4B$105.65B
2012-12-315.81%$6.17B$106.13B
2011-12-315.97%$6.27B$105.13B
2010-12-310.81%$861M$105.78B
2009-12-3111.48%$12.9B$112.31B
2008-12-3116.54%$7.81B$47.2B

Similar stocks

Stock NameCountryMarket CapPE Ratio
AbbVie Inc. (ABBV)United States$468.180B70.37
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94
Zoetis Inc. (ZTS)United States$29.045B11.38
INSMED Inc (INSM)United States$26.566B-26.60